AtriCure Q2 FY26 net income turns to USD 9 million; revenue rises 12.8% to USD 153.6 million
ATRC•Full-year 2026 outlook
AtriCure forecast full-year 2026 revenue of USD 602 million to USD 610 million and expects adjusted EBITDA (non-GAAP) of USD 85 million to USD 89 million.
Q2 revenue and profitability improve
AtriCure reported Q2 2026 revenue of USD 153.6 million, up 12.8% year over year.
Operating income swung to USD 9.7 million from an operating loss a year earlier; net income was USD 9 million, or USD 0.18 a share.
Gross margin widened 2.69 percentage points to 77.2%.
Adjusted EBITDA and cash generation rise
Adjusted EBITDA (non-GAAP) rose 78% to USD 27.3 million; cash generation was USD 21.6 million.
